You are viewing the site in preview mode

Skip to main content

Table 3 Significant peptide peaks differentiating BTC from healthy volunteers

From: Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling

Mass (m/z) Peak area Peak area Fold- change Wilcoxon test AUROC
  BTC +/- SD H +/- SD (BTC vs H) P value  
887.2 5.2+/-7.1 1.8+/-0.5 2.82 0.000691 0.79
1263.7 21.8+/-9.9 47.4+/-22.7 0.46 <0.000001 0.91
1350.8 48.3+/-25.7 117.4+/-62.3 0.41 <0.000001 0.92
2082.1 10.0+/-3.4 24.4+/-20.5 0.41 0.0000364 0.86
2210.3 10.9+/-3.8 38.2+/-31.6 0.29 <0.000001 0.92
2554.5 24.8+/-17.8 57.3+/-20.6 0.43 <0.000001 0.91
2903.3 24.1+/-10.0 11.5+/-2.5 2.09 <0.000001 0.97
5805.0 33.0+/-30.9 6.7+/-1.6 4.93 <0.000001 0.96
  1. *Wilcoxon test P values were corrected for multiple testing using the Benjamini-Hochberg adjustment. Area under the Receiver Operating Characteristic curve.